Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model

Molecular Carcinogenesis

Volumn 54, Issue 10, 2015, Pages 999-1013

  Sobolewski, Cyril ^a   Muller, Florian ^a   Cerella, Claudia ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Apoptosis; Celecoxib; Cell cycle; COX 2; Curcumin

Indexed keywords

CELECOXIB; CURCUMIN; CYCLIN D1; PROTEIN P27; CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CURCUMA LONGA; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; JURKAT CELL LINE; K562 CELL LINE; PRIORITY JOURNAL; RAJI CELL LINE; TUMOR GROWTH; U937 CELL LINE; CELL CYCLE; DRUG EFFECTS; GENETICS; TUMOR CELL LINE;

APOPTOSIS; CELECOXIB; CELL CYCLE; CELL LINE, TUMOR; CURCUMIN; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; HUMANS; JURKAT CELLS; K562 CELLS; U937 CELLS;

EID: 84941645375     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22169     Document Type: Article

References (64)

1. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001; 357:539-545.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-867.
3. Aggarwal BB. Nuclear factor-kappaB: The enemy within. Cancer Cell 2004; 6:203-208.
4. Chen R, Alvero AB, Silasi DA, Mor G. Inflammation, cancer and chemoresistance: Taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol 2007; 57:93-107.
5. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. Faseb J 1998; 12:1063-1073.
6. Chandrasekharan NV, Simmons DL. The cyclooxygenases. Genome Biol 2004; 5:241.
7. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 2006; 38:1654-1661.
8. Sobolewski C, Cerella C, Dicato M, Ghibelli L, Diederich M. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol 2010; 2010:215158.
9. Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 2002; 190:279-286.
10. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. Faseb J 2001; 15:2057-2072.
11. Steffel J, Luscher TF, Ruschitzka F, Tanner FC. Cyclooxygenase-2 inhibition and coagulation. J Cardiovasc Pharmacol 2006; 47:S15-S20.
12. van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. What is the harm-benefit ratio of Cox-2 inhibitors? Int J Epidemiol 2008; 37:405-413.
13. Whelton A, Fort JG, Puma JA, Normandin D, Bello AE, Verburg KM. Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther 2001; 8:85-95.
14. Mat Saad, AZ, Collins N, Lobo MM, O'Connor HJ. Proton pump inhibitors: A survey of prescribing in an Irish general hospital. Int J Clin Pract 2005; 59:31-34.
15. Lev-Ari S, Strier L, Kazanov D, et al. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 2005; 11:6738-6744.
16. Adhami VM, Malik A, Zaman N, et al. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 2007; 13:1611-1619.
17. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3:768-780.
18. Cerella C, Sobolewski C, Dicato M, Diederich M. Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy. Biochem Pharmacol 2010; 80:1801-1815.
19. Duvoix A, Blasius R, Delhalle S, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005; 223:181-190.
20. Teiten MH, Eifes S, Reuter S, Duvoix A, Dicato M, Diederich M. Gene expression profiling related to anti-inflammatory properties of curcumin in K562 leukemia cells. Ann NY Acad Sci 2009; 1171:391-398.
21. Teiten MH, Reuter S, Schmucker S, Dicato M, Diederich M. Induction of heat shock response by curcumin in human leukemia cells. Cancer Lett 2009; 279:145-154.
22. Kelkel M, Jacob C, Dicato M, Diederich M. Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies. Molecules 2010; 15:7035-7074.
23. Teiten MH, Eifes S, Dicato M, Diederich M. Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) 2010; 2:128-162.
24. Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 2008; 76:1340-1351.
25. Reuter S, Schnekenburger M, Cristofanon S, et al. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochem Pharmacol 2009; 77:397-411.
26. Marin YE, Wall BA, Wang S, et al. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res 2007; 17:274-283.
27. Singh M, Singh N. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol Cell Biochem 2009; 325:107-119.
28. Kim KC, Lee C. Curcumin induces downregulation of E2F4 expression and apoptotic cell death in HCT116 human colon cancer cells; involvement of reactive oxygen species. Korean J Physiol Pharmacol 2010; 14:391-397.
29. Reuter S, Charlet J, Juncker T, Teiten MH, Dicato M, Diederich M. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells. Ann NY Acad Sci 2009; 1171:436-447.
30. Weber WM, Hunsaker LA, Gonzales AM, et al. TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Biochem Pharmacol 2006; 72:928-940.
31. Blasius R, Reuter S, Henry E, Dicato M, Diederich M. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells. Biochem Pharmacol 2006; 72:1547-1554.
32. Duvoix A, Morceau F, Delhalle S, et al. Induction of apoptosis by curcumin: Mediation by glutathione S-transferase P1-1 in hibition. Biochem Pharmacol 2003; 66:1475-1483.
33. Teiten MH, Gaascht F, Eifes S, Dicato M, Diederich M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 2010; 5:61-74.
34. Teiten MH, Gaascht F, Dicato M, Diederich M. Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents. Curr Pharm Biotechnol 2011; 13:245-254.
35. Giladi N, Kazanov D, Shpitz B, Aroch I, Kraus S, Arber N. Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer. Expert Opin Investig Drugs 2010; 19:S117-S124.
36. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011; 10:12.
37. Sobolewski C, Cerella C, Dicato M, Diederich M. Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells. Cell Cycle 2011; 10:2978-2993.
38. Juncker T, Cerella C, Teiten MH, et al. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells. Biochem Pharmacol 2011; 81:13-23.
39. Cerella C, Sobolewski C, Chateauvieux S, et al. COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells. Biochem Pharmacol 2011; 82:1277-1290.
40. Cerella C, Dicato M, Jacob C, Diederich M. Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds. Anticancer Agents Med Chem 2011; 11:267-271.
41. Schonthal AH. Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: Implications for glioma therapy. Neurosurg Focus 2006; 20:E21.
42. Blasius R, Dicato M, Diederich M. Effect of curcumin treatment on protein phosphorylation in K562 cells. Ann NY Acad Sci 2007; 1095:377-387.
43. Yadav B, Taurin S, Rosengren RJ, et al. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorg Med Chem 2010; 18:6701-6707.
44. Azmi AS, Ali S, Banerjee S, et al. Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism. Am J Transl Res 2011; 3:374-382.
45. Duvoix A, Morceau F, Schnekenburger M, et al. Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat. Ann NY Acad Sci 2003; 1010:389-392.
46. Lee DS, Lee MK, Kim JH. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Anticancer Res 2009; 29:5039-5044.
47. Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M, Diederich M. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol 2011; 38:603-611.
48. Blasius R, Duvoix A, Morceau F, et al. Curcumin stability and its effect on glutathione S-transferase P1-1 mRNA expression in K562 cells. Ann NY Acad Sci 2004; 1030:442-448.
49. Liu HS, Ke CS, Cheng HC, Huang CY, Su CL. Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells is partly through inhibition of Aurora-A. Mol Pharmacol 2011; 80:638-646.
50. Katayama H, Brinkley WR, Sen S. The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Rev 2003; 22:451-464.
51. Perez Fidalgo JA, Roda D, Rosello S, Rodriguez-Braun E, Cervantes A, Aurora kinase inhibitors: A new class of drugs targeting the regulatory mitotic system. Clin Transl Oncol 2009; 11:787-798.
52. Song L, Li D, Liu R, Zhou H, Chen J, Huang X. Ser-10 phosphorylated histone H3 is involved in cytokinesis as a chromosomal passenger. Cell Biol Int 2007; 31:1184-1190.
53. Dempe JS, Pfeiffer E, Grimm AS, Metzler M. Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells. Mol Nutr Food Res 2008; 52:1074-1081.
54. Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011; 12:385-392.
55. Wolanin K, Magalska A, Mosieniak G, et al. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells. Mol Cancer Res 2006; 4:457-469.
56. Lev-Ari S, Zinger H, Kazanov D, et al. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Biomed Pharmacother 2005; 59:S276-S280.
57. Shpitz B, Giladi N, Sagiv E, et al. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion 2006; 74:140-144.
58. Goel A, Aggarwal BB. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 2010; 62:919-930.
59. Yogosawa S, Yamada Y, Yasuda S, Sun Q, Takizawa K, Sakai T. Dehydrozingerone, a structural analogue of curcumin, induces cell-cycle arrest at the G2/M phase and accumulates intracellular ROS in HT-29 human colon cancer cells. J Nat Prod 2012; 75:2088-2093.
60. Kumaravel M, Sankar P, Rukkumani R. Antiproliferative effect of an analog of curcumin bis-1, 7-(2-hydroxyphenyl)-hepta-1, 6-diene-3, 5-dione in human breast cancer cells. Eur Rev Med Pharmacol Sci 2012; 16:1900-1907.
61. Gonzalez-Sarrias A, Ma H, Edmonds ME, Seeram NP. Maple polyphenols, ginnalins A-C, induce S- and G2/M-cell cycle arrest in colon and breast cancer cells mediated by decreasing cyclins A and D1 levels. Food Chem 2013; 136:636-642.
62. Kelkel M, Cerella C, Mack F, et al. ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis. Carcinogenesis 2012; 33:2162-2171.
63. Lu JJ, Cai YJ, Ding J. Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells. Mol Cell Biochem 2011; 354:247-252.
64. Sahu RP, Batra S, Srivastava SK. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 2009; 100:1425-1433.